{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T08:13:38Z","timestamp":1781597618992,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"The Danish Rheumatism Association","award":["R114-A2671"],"award-info":[{"award-number":["R114-A2671"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13075-017-1282-4","type":"journal-article","created":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T12:15:47Z","timestamp":1493208947000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Increased galectin-3 may serve as a serologic signature of pre-rheumatoid arthritis while markers of synovitis and cartilage do not differ between early undifferentiated arthritis subsets"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8520-1511","authenticated-orcid":false,"given":"Saida Farah","family":"Issa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Duer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikkel","family":"\u00d8stergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"H\u00f8rslev-Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merete L.","family":"Hetland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Sejer","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Junker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne M.","family":"Lindegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob M.","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Junker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,26]]},"reference":[{"issue":"2","key":"1282_CR1","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1136\/annrheumdis-2011-200205","volume":"71","author":"A Krabben","year":"2012","unstructured":"Krabben A, Huizinga TW, van der Helm-van Mil AH. Undifferentiated arthritis characteristics and outcomes when applying the 2010 and 1987 criteria for rheumatoid arthritis. Ann Rheum Dis. 2012;71(2):238\u201341.","journal-title":"Ann Rheum Dis"},{"issue":"5 Suppl 35","key":"1282_CR2","first-page":"S12","volume":"22","author":"KN Verpoort","year":"2004","unstructured":"Verpoort KN, van Dongen H, Allaart CF, Toes RE, Breedveld FC, Huizinga TW. Undifferentiated arthritis\u2014disease course assessed in several inception cohorts. Clin Exp Rheumatol. 2004;22(5 Suppl 35):S12\u20137.","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"1282_CR3","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1093\/rheumatology\/35.11.1096","volume":"35","author":"BJ Harrison","year":"1996","unstructured":"Harrison BJ, Symmons DPM, Brennan P, Barrett EM, Silman AJ. Natural remission in inflammatory polyarthritis: issues of definition and prediction. Br J Rheumatol. 1996;35(11):1096\u2013100.","journal-title":"Br J Rheumatol"},{"issue":"9","key":"1282_CR4","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1093\/rheumatology\/39.9.939","volume":"39","author":"B Harrison","year":"2000","unstructured":"Harrison B, Symmons D. Early inflammatory polyarthritis: results from the Norfolk Arthritis Register with a review of the literature. II. Outcome at three years. Rheumatology (Oxford, England). 2000;39(9):939\u201349.","journal-title":"Rheumatology (Oxford, England)"},{"issue":"3","key":"1282_CR5","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/03009740600718080","volume":"35","author":"JE Oliver","year":"2006","unstructured":"Oliver JE, Silman AJ. Risk factors for the development of rheumatoid arthritis. Scand J Rheumatol. 2006;35(3):169\u201374.","journal-title":"Scand J Rheumatol"},{"issue":"7","key":"1282_CR6","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1136\/ard.2006.051391","volume":"65","author":"J Avouac","year":"2006","unstructured":"Avouac J, Gossec L, Dougados M. Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis. 2006;65(7):845\u201351.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1282_CR7","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/art.20018","volume":"50","author":"MMJ Nielen","year":"2004","unstructured":"Nielen MMJ, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MHMT, Habibuw MR, Vandenbroucke JP, Dijkmans BAC. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum. 2004;50(2):380\u20136.","journal-title":"Arthritis Rheum"},{"key":"1282_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3899\/jrheum.101069","volume":"87","author":"W Vercoutere","year":"2011","unstructured":"Vercoutere W, Thevissen K, Bombardier C, Landewe RB. Diagnostic and predictive value of acute-phase reactants in adult undifferentiated peripheral inflammatory arthritis: a systematic review. J Rheumatol Suppl. 2011;87:15\u20139.","journal-title":"J Rheumatol Suppl."},{"key":"1282_CR9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3899\/jrheum.101070","volume":"87","author":"M Schoels","year":"2011","unstructured":"Schoels M, Bombardier C, Aletaha D. Diagnostic and prognostic value of antibodies and soluble biomarkers in undifferentiated peripheral inflammatory arthritis: a systematic review. J Rheumatol Suppl. 2011;87:20\u20135.","journal-title":"J Rheumatol Suppl."},{"issue":"8","key":"1282_CR10","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1002\/art.23681","volume":"58","author":"AH Mil van der Helm-van","year":"2008","unstructured":"van der Helm-van Mil AH, Detert J, le Cessie S, Filer A, Bastian H, Burmester GR, Huizinga TW, Raza K. Validation of a prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: moving toward individualized treatment decision-making. Arthritis Rheum. 2008;58(8):2241\u20137.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"1282_CR11","first-page":"686","volume":"28","author":"F Salaffi","year":"2010","unstructured":"Salaffi F, Ciapetti A, Gasparini S, Carotti M, Filippucci E, Grassi W. A clinical prediction rule combining routine assessment and power Doppler ultrasonography for predicting progression to rheumatoid arthritis from early-onset undifferentiated arthritis. Clin Exp Rheumatol. 2010;28(5):686\u201394.","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"1282_CR12","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1002\/art.30396","volume":"63","author":"A Duer-Jensen","year":"2011","unstructured":"Duer-Jensen A, Horslev-Petersen K, Hetland ML, Bak L, Ejbjerg BJ, Hansen MS, Johansen JS, Lindegaard HM, Vinterberg H, Moller JM, et al. Bone edema on magnetic resonance imaging is an independent predictor of rheumatoid arthritis development in patients with early undifferentiated arthritis. Arthritis Rheum. 2011;63(8):2192\u2013202.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1282_CR13","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/art.30118","volume":"63","author":"H Forsman","year":"2011","unstructured":"Forsman H, Islander U, Andreasson E, Andersson A, Onnheim K, Karlstrom A, Savman K, Magnusson M, Brown KL, Karlsson A. Galectin 3 aggravates joint inflammation and destruction in antigen-induced arthritis. Arthritis Rheum. 2011;63(2):445\u201354.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"1282_CR14","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1002\/art.11287","volume":"48","author":"S Ohshima","year":"2003","unstructured":"Ohshima S, Kuchen S, Seemayer CA, Kyburz D, Hirt A, Klinzing S, Michel BA, Gay RE, Liu FT, Gay S, et al. Galectin 3 and its binding protein in rheumatoid arthritis. Arthritis Rheum. 2003;48(10):2788\u201395.","journal-title":"Arthritis Rheum"},{"key":"1282_CR15","first-page":"146","volume-title":"American College of Rheumatology: 2014","author":"SF Issa","year":"2014","unstructured":"Issa SF, Christensen AF, Lindegaard HM, Hetland ML, Horslev-Petersen K, Junker K, Stengaard-Pedersen K, Lottenburger T, Ellingsen T, Hansen I, et al. Galectin-3 in the systemic circulation is increased in newly diagnosed rheumatoid arthritis and is associated with anti-CCP and bone marrow edema. In: American College of Rheumatology: 2014. Boston, MA: Arthritis & Rheumatology; 2014. p. 146."},{"issue":"6","key":"1282_CR16","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.joca.2004.02.004","volume":"12","author":"JC Rousseau","year":"2004","unstructured":"Rousseau JC, Zhu Y, Miossec P, Vignon E, Sandell LJ, Garnero P, Delmas PD. Serum levels of type IIA procollagen amino terminal propeptide (PIIANP) are decreased in patients with knees osteoarthritis and rheumatoid arthritis. Osteoarthr Cartil. 2004;12(6):440\u20137.","journal-title":"Osteoarthr Cartil"},{"issue":"2","key":"1282_CR17","first-page":"307","volume":"27","author":"AF Christensen","year":"2009","unstructured":"Christensen AF, Lottenburger T, Lindegaard H, Christgau S, Horslev-Petersen K, Junker P. Differential association of the N-propeptide of collagen IIA (PIIANP) and collagen II C-telopeptide (CTX-II) with synovitis and erosions in early and longstanding rheumatoid arthritis. Clin Exp Rheumatol. 2009;27(2):307\u201314.","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"1282_CR18","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3899\/jrheum.091265","volume":"37","author":"AF Christensen","year":"2010","unstructured":"Christensen AF, Horslev-Petersen K, Christgau S, Lindegaard HM, Lottenburger T, Junker K, Hetland ML, Stengaard-Pedersen K, Jacobsen S, Ellingsen T, et al. Uncoupling of collagen II metabolism in newly diagnosed, untreated rheumatoid arthritis is linked to inflammation and antibodies against cyclic citrullinated peptides. J Rheumatol. 2010;37(6):1113\u201320.","journal-title":"J Rheumatol"},{"issue":"6","key":"1282_CR19","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1002\/art.1780330605","volume":"33","author":"AR Poole","year":"1990","unstructured":"Poole AR, Witter J, Roberts N, Piccolo F, Brandt R, Paquin J, Baron M. Inflammation and cartilage metabolism in rheumatoid arthritis. Studies of the blood markers hyaluronic acid, orosomucoid, and keratan sulfate. Arthritis Rheum. 1990;33(6):790\u20139.","journal-title":"Arthritis Rheum"},{"issue":"12","key":"1282_CR20","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/art.1780301203","volume":"30","author":"A Engstrom-Laurent","year":"1987","unstructured":"Engstrom-Laurent A, Hallgren R. Circulating hyaluronic acid levels vary with physical activity in healthy subjects and in rheumatoid arthritis patients. Relationship to synovitis mass and morning stiffness. Arthritis Rheum. 1987;30(12):1333\u20138.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"1282_CR21","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1002\/art.21796","volume":"54","author":"ML Hetland","year":"2006","unstructured":"Hetland ML, Stengaard-Pedersen K, Junker P, Lottenburger T, Ellingsen T, Andersen LS, Hansen I, Skjodt H, Pedersen JK, Lauridsen UB, et al. Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled study. Arthritis Rheum. 2006;54(5):1401\u20139.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"1282_CR22","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1136\/annrheumdis-2013-204537","volume":"74","author":"MB Axelsen","year":"2015","unstructured":"Axelsen MB, Eshed I, H\u00f8rslev-Petersen K, Stengaard-Pedersen K, Hetland ML, M\u00f8ller J, Junker P, P\u00f8denphant J, Schlemmer A, Ellingsen T, et al. A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trial. Ann Rheum Dis. 2015;74(5):867\u201375.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1282_CR23","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315\u201324.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"1282_CR24","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1093\/rheumatology\/kel409","volume":"46","author":"M Sharif","year":"2007","unstructured":"Sharif M, Kirwan J, Charni N, Sandell LJ, Whittles C, Garnero P. A 5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis\u2014association with disease progression. Rheumatology (Oxford). 2007;46(6):938\u201343.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"1282_CR25","first-page":"1385","volume":"30","author":"M Ostergaard","year":"2003","unstructured":"Ostergaard M, Peterfy C, Conaghan P, McQueen F, Bird P, Ejbjerg B, Shnier R, O\u2019Connor P, Klarlund M, Emery P, et al. OMERACT rheumatoid arthritis magnetic resonance imaging studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system. J Rheumatol. 2003;30(6):1385\u20136.","journal-title":"J Rheumatol"},{"issue":"2","key":"1282_CR26","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/art.22380","volume":"56","author":"AH Mil van der Helm-van","year":"2007","unstructured":"van der Helm-van Mil AH, le Cessie S, van Dongen H, Breedveld FC, Toes RE, Huizinga TW. A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: how to guide individual treatment decisions. Arthritis Rheum. 2007;56(2):433\u201340.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"1282_CR27","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1002\/art.24574","volume":"60","author":"A Filer","year":"2009","unstructured":"Filer A, Bik M, Parsonage GN, Fitton J, Trebilcock E, Howlett K, Cook M, Raza K, Simmons DL, Thomas AM, et al. Galectin 3 induces a distinctive pattern of cytokine and chemokine production in rheumatoid synovial fibroblasts via selective signaling pathways. Arthritis Rheum. 2009;60(6):1604\u201314.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"1282_CR28","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1136\/ard.2003.014233","volume":"63","author":"K Forslind","year":"2004","unstructured":"Forslind K, Ahlm\u00e9n M, Eberhardt K, Hafstr\u00f6m I, Svensson B. Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP). Ann Rheum Dis. 2004;63(9):1090\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1282_CR29","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/art.11481","volume":"50","author":"ET Molenaar","year":"2004","unstructured":"Molenaar ET, Voskuyl AE, Dinant HJ, Bezemer PD, Boers M, Dijkmans BA. Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission. Arthritis Rheum. 2004;50(1):36\u201342.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1282_CR30","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3899\/jrheum.131088","volume":"41","author":"F Gandjbakhch","year":"2014","unstructured":"Gandjbakhch F, Haavardsholm EA, Conaghan PG, Ejbjerg B, Foltz V, Brown AK, Dohn UM, Lassere M, Freeston JE, Olsen IC, et al. Determining a magnetic resonance imaging inflammatory activity acceptable state without subsequent radiographic progression in rheumatoid arthritis: results from a follow-up MRI study of 254 patients in clinical remission or low disease activity. J Rheumatol. 2014;41(2):398\u2013406.","journal-title":"J Rheumatol"},{"issue":"2","key":"1282_CR31","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3109\/03009742.2015.1070902","volume":"45","author":"K Forslind","year":"2016","unstructured":"Forslind K, Svensson B. MRI evidence of persistent joint inflammation and progressive joint damage despite clinical remission during treatment of early rheumatoid arthritis. Scand J Rheumatol. 2016;45(2):99\u2013102.","journal-title":"Scand J Rheumatol"},{"issue":"5","key":"1282_CR32","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/art.39550","volume":"68","author":"WP Nieuwenhuis","year":"2016","unstructured":"Nieuwenhuis WP, van Steenbergen HW, Stomp W, Stijnen T, Huizinga TW, Bloem JL, van der Heijde D, Reijnierse M, van der Helm-van Mil AH. The course of bone marrow edema in early undifferentiated arthritis and rheumatoid arthritis: a longitudinal magnetic resonance imaging study at bone level. Arthritis Rheumatol (Hoboken, NJ). 2016;68(5):1080\u20138.","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"issue":"3","key":"1282_CR33","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1136\/ard.2004.023135","volume":"64","author":"M Neidhart","year":"2005","unstructured":"Neidhart M, Zaucke F, von Knoch R, Jungel A, Michel BA, Gay RE, Gay S. Galectin-3 is induced in rheumatoid arthritis synovial fibroblasts after adhesion to cartilage oligomeric matrix protein. Ann Rheum Dis. 2005;64(3):419\u201324.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1282_CR34","doi-asserted-by":"publisher","first-page":"R458","DOI":"10.1186\/ar1697","volume":"7","author":"K Lundberg","year":"2005","unstructured":"Lundberg K, Nijenhuis S, Vossenaar ER, Palmblad K, van Venrooij WJ, Klareskog L, Zendman AJ, Harris HE. Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity. Arthritis Res Ther. 2005;7(3):R458\u201367.","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"1282_CR35","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1172\/JCI25422","volume":"116","author":"KA Kuhn","year":"2006","unstructured":"Kuhn KA, Kulik L, Tomooka B, Braschler KJ, Arend WP, Robinson WH, Holers VM. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest. 2006;116(4):961\u201373.","journal-title":"J Clin Invest"},{"issue":"7","key":"1282_CR36","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1002\/art.24622","volume":"60","author":"LA Trouw","year":"2009","unstructured":"Trouw LA, Haisma EM, Levarht EW, van der Woude D, Ioan-Facsinay A, Daha MR, Huizinga TW, Toes RE. Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways. Arthritis Rheum. 2009;60(7):1923\u201331.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1282_CR37","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00296-015-3397-8","volume":"36","author":"HL Munk","year":"2016","unstructured":"Munk HL, Gudmann NS, Christensen AF, Ejstrup L, Sorensen GL, Loft AG, Bay-Jensen AC, Siebuhr AS, Junker P. Cartilage collagen type II seromarker patterns in axial spondyloarthritis and psoriatic arthritis: associations with disease activity, smoking and HLA-B27. Rheumatol Int. 2016;36(4):541\u20139.","journal-title":"Rheumatol Int"},{"issue":"1","key":"1282_CR38","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/art.23148","volume":"58","author":"M Oosterhout van","year":"2008","unstructured":"van Oosterhout M, Bajema I, Levarht EW, Toes RE, Huizinga TW, van Laar JM. Differences in synovial tissue infiltrates between anti-cyclic citrullinated peptide-positive rheumatoid arthritis and anti-cyclic citrullinated peptide-negative rheumatoid arthritis. Arthritis Rheum. 2008;58(1):53\u201360.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"1282_CR39","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569\u201381.","journal-title":"Arthritis Rheum"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-017-1282-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T19:57:43Z","timestamp":1719172663000},"score":1,"resource":{"primary":{"URL":"http:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-017-1282-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,26]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1282"],"URL":"https:\/\/doi.org\/10.1186\/s13075-017-1282-4","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,26]]},"article-number":"80"}}